Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Tolmachev
Vladimir
V
Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. Vladimir.Tolmachev@bms.uu.se
Orlova
Anna
A
Wei
Qichun
Q
Bruskin
Alexander
A
Carlsson
Jörgen
J
Gedda
Lars
L
D000818:Animals; D004815:Epidermal Growth Factor / Q000493:pharmacokinetics*; D066246:ErbB Receptors / Q000378:metabolism; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy*; D007205:Indium Radioisotopes / Q000493:pharmacokinetics*; D017879:Isothiocyanates / Q000493:pharmacokinetics*; D051379:Mice; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*
C478252:111In-DTPA-human epidermal growth factor; D007205:Indium Radioisotopes; D017879:Isothiocyanates; D019275:Radiopharmaceuticals; C485704:isothiocyanate-benzyl-DTPA; D004815:Epidermal Growth Factor; D004369:Pentetic Acid; D066246:ErbB Receptors